Literature DB >> 28865304

Hypocoagulability as assessed by thrombin generation test in newly-diagnosed patients with multiple myeloma.

Pauline Legendre1, Emma Verstraete2, Michèle Martin3, Amélie Poinsard2, Aurore Perrot4, Cyrille Hulin5, Gilbert Faure6, Véronique Latger-Cannard7, Julien Perrin8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28865304     DOI： 10.1016/j.bcmd.2017.08.011

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  5 in total

1.  Patients With Multiple Myeloma Have a Disbalanced Whole Blood Thrombin Generation Profile.

Authors:  Li Li; Mark Roest; Yaqiu Sang; Jasper A Remijn; Rob Fijnheer; Karel Smit; Dana Huskens; Jun Wan; Bas de Laat; Joke Konings
Journal:  Front Cardiovasc Med       Date:  2022-06-27

2.  Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.

Authors:  Despina Fotiou; Theodoros N Sergentanis; Loula Papageorgiou; Kimon Stamatelopoulos; Maria Gavriatopoulou; Efstathios Kastritis; Theodora Psaltopoulou; Stella Salta; Patrick Van Dreden; Rabiatou Sangare; Annette K Larsen; Evangelos Terpos; Ismail Elalamy; Meletios A Dimopoulos; Grigoris T Gerotziafas
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

3.  Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study.

Authors:  Emilie Chalayer; Brigitte Tardy-Poncet; Lionel Karlin; Céline Chapelle; Aurélie Montmartin; Michèle Piot; Denis Guyotat; Philippe Collet; Thomas Lecompte; Bernard Tardy
Journal:  Res Pract Thromb Haemost       Date:  2018-12-13

Review 4.  Potential mechanisms of resistance to current anti-thrombotic strategies in Multiple Myeloma.

Authors:  Claire Comerford; Siobhan Glavey; Jamie M O'Sullivan; John Quinn
Journal:  Cancer Drug Resist       Date:  2022-03-07

Review 5.  The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies.

Authors:  Claire Comerford; Siobhan Glavey; John Quinn; Jamie M O'Sullivan
Journal:  J Thromb Haemost       Date:  2022-06-23       Impact factor: 16.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.